Literature DB >> 17599982

Gadolinium contrast may be risky in kidney disease.

Peter C Thomson, Tara A Collidge, Patrick B Mark, Jamie P Traynor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17599982      PMCID： PMC1906672          DOI： 10.1136/bmj.39254.924641.1F

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

2.  Diagnosis of peripheral arterial disease of the lower limb.

Authors:  Andrew W Bradbury; Donald J Adam
Journal:  BMJ       Date:  2007-06-16

3.  Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned.

Authors:  Dale R Broome; Mark S Girguis; Pedro W Baron; Alfred C Cottrell; Ingrid Kjellin; Gerald A Kirk
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

4.  Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.

Authors:  Tara Anne Collidge; Peter Campbell Thomson; Patrick Barry Mark; James Phillip Traynor; Alan George Jardine; Scott Thomas William Morris; Keith Simpson; Giles Hannibal Roditi
Journal:  Radiology       Date:  2007-08-17       Impact factor: 11.105

Review 5.  Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review.

Authors:  Ros Collins; Jane Burch; Gillian Cranny; Raquel Aguiar-Ibáñez; Dawn Craig; Kath Wright; Elizabeth Berry; Michael Gough; Jos Kleijnen; Marie Westwood
Journal:  BMJ       Date:  2007-06-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.